Trans-( &#b1;)-2,4,6-substituted-5,5a,6,7,8,9,9a,10-octahydro-pyrimido[4,5-g]quino lines
Patent 4501890 Issued on February 26, 1985. Estimated Expiration Date: 
September 26, 2003. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
September 26, 2003. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesProlactin inhibiting octahydro pyrazolo[3,4-g]quinolines Patent #: 4198415 InventorsAssigneeApplicationNo. 06/535503 filed on 09/26/1983US Classes:514/267, Tricyclo ring system having 1,3-diazine as one of the cyclos544/250, Three or more ring hetero atoms in the tricyclo ring system546/164, Fully saturated quinolines546/165Single bond between 1,2-positions and single bond between 3,4-positionsExaminersPrimary: Daus, Donald G.Assistant: Shen, Cecilia Attorney, Agent or FirmInternational ClassesC07D 215/00 (20060101)C07D 215/20 (20060101) C07D 471/00 (20060101) C07D 471/04 (20060101) AbstractTrans-(&#b1;)-2-Amino or substituted amino-4-permissibly-substituted 6-lower alkyl or allyl-5,5a,-6,7,8,9,9a,10-octahydropyrimido[4,5-g]quinolines, the corresponding trans-(-)-stereoisomers and salts thereof, useful in treating anxiety, Parkinson's Syndrome, sexual dysfunction, depression, hypertension and elevated prolactin levels, and intermediates useful for the synthesis thereof. |
| ||||||||||||||
